Priority Date: 26.06.12 (EP 20120004764)

N-[4-(QUINOLIN-4-YLOXY)CYCLOHEXYL(METHYL)](HETERO)ARYLCARBOXAMIDES AS ANDROGEN RECEPTOR ANTAGONISTS, PRODUCTION AND USE THEREOF AS MEDICINAL PRODUCTS

  • Application ID: EP13731325
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Technology company logo thumb
no operation time available
3 offices
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 186 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 26.06.2012 - Priority Date (EP 20120004764)
  • 03.01.2014 - Publication A1 (WO2014001247)
  • 29.04.2015 - Publication A1 (EP2864291)
  • 05.10.2016 - Publication B1 (EP2864291)